Öksüzoglu, B. Et Al. 2008. Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. Chemotherapy , vol.54, no.5 , 352-356.

Öksüzoglu, B., Abali, H., HAYRAN, K. M., Yildirim, N., Budakoglu, B., & ZENGİN, N., (2008). Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. Chemotherapy , vol.54, no.5, 352-356.

Öksüzoglu, Berna Et Al. "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes," Chemotherapy , vol.54, no.5, 352-356, 2008

Öksüzoglu, Berna Et Al. "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes." Chemotherapy , vol.54, no.5, pp.352-356, 2008

Öksüzoglu, B. Et Al. (2008) . "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes." Chemotherapy , vol.54, no.5, pp.352-356.

@article{article, author={Berna Öksüzoglu Et Al. }, title={Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes}, journal={Chemotherapy}, year=2008, pages={352-356} }